Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Cagrilintide for Sale > Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3
Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3 buy - large image1
Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3 buy - image1
Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3 buy - image2
Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3 buy - image3
Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3 buy - image4
Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3 buy - image5
Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3 buy - image6

Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3

62 Inquiries

Unit Price:

$180/UNIT FOB

Get Latest Price
CAS No.:

1415456-99-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shenzhen

Brand:

ZQ

Packaging:

10mg/vials,10vials/box

Price valid (until):

2027-01-01

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Semaglutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Sales manager:Nico
    WhatsApp:+86 158 0329 3896
    Email:nico@sjzenshi.com


      Product Detail  


    Cagrilintide is a new long-acting acylated amylin analog under development. The following is an introduction to this product:
    Mechanism of Action: As a non-selective amylin receptor (AMYR) and calcitonin G-protein-coupled receptor (CTR) agonist, cagrilintide induces significant weight loss and reduced food intake.

    Items Specifications

    Product Name

    Cagrilintide

    Cas No.

    1415456-99-3

    MF

    C194H312N54O59S2

    Appearance

    White powder

    Customized

    Customized

    Shelf Life

    2 Years When Properly Stored

    Storage

    Keep in a cool, dry, dark location in a tightly sealed container or cylinder.


    Shop Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3-Detailed Image 1


      Application  


    1. R&D company:  Novo Nordisk

    Shop Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3-Detailed Image 2

    2. Type of drug:  Long-acting amylin analog

    Shop Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3-Detailed Image 3

    3. Mechanism of action:  Achieve weight loss by delaying gastric emptying, reducing energy intake and regulating food choices and preferences. It can also inhibit postprandial glucagon release and exert glucose regulation.

    Shop Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3-Detailed Image 4



      Clinical studies


    Clinical studies:
    In clinical studies of combined use with semaglutide 2.4 mg, the average weight loss of subjects at week 20 (15.7%, 17.1%) was greater than that of the placebo group (9.8%). *A study published in The Lancet showed that cagrilintide combined with semaglutide 2.4 mg is safe and effective for weight control.
    R&D stage: It has entered the Phase III clinical research stage, targeting overweight or obese patients for weight loss treatment.
    In short, cagrilintide is a drug with significant weight loss effect and is currently in the clinical research stage. It achieves weight loss by regulating amylin levels, providing a new treatment option for obese patients.

    Shop Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3-Detailed Image 5


      Product attributes  


    Shop Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3-Detailed Image 6

    Shop Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3-Detailed Image 7


      Product packaging and shippinga


    Shop Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3-Detailed Image 8

    Shop Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3-Detailed Image 9


      Company Profile  


    Changsha Duole Technology Co., Ltd.,   located in Changsha City, Hunan Province, is a high-tech enterprise focusing on the research, development and production of peptide products. The company was established in recent years and is committed to applying advanced biotechnology to the health industry to meet the market's demand for high-quality, high-efficiency peptide products.
    As a leading peptide manufacturer, Dole Technology has a R&D team composed of senior scientists and engineers, which continues to explore and innovate, and is committed to developing safer, more effective, and more market-competitive peptide products. The company's main products cover but are not limited to pharmaceutical grade, food grade and cosmetic grade and other fields, and are widely used in many aspects such as health care, disease prevention, beauty and skin care.

    In terms of production technology, Dole Technology adopts internationally advanced production equipment and technology to ensure that every aspect of the product, from raw material selection, production and processing to finished product packaging, strictly follows relevant national standards and specifications to ensure product quality and safety. At the same time, the company has also established a complete quality management system and after-sales service system to provide customers with all-round, one-stop service support.
    Duole Technology adheres to the corporate philosophy of "technology leads health, quality creates the future" and always adheres to the development path of people-oriented and technological innovation. The company not only focuses on product quality and innovation, but also actively fulfills its social responsibilities and is committed to promoting the development and progress of the health industry.

    In the future, Changsha Duole Technology Co., Ltd. will continue to delve into the field of peptide product research and development, continue to explore and make breakthroughs, and strive to become a leader in the global peptide industry and make greater contributions to human health.

    Shop Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3-Detailed Image 10


      Certificates and exhibitions  


    Shop Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3-Detailed Image 11

    Shop Cagri sema tirz reta nad+ vip etc. Peptide products, pharmaceutical intermediates CAS:1415456-99-3-Detailed Image 12

    ECHEMI Editorial Reference

    Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    Cagrilintide;Cargliptin;Caglitide;Cagrilintide acetate;Cagrilintide peptide;Cagrilintide 5mg 10mg 15mg;Cagrilintide(Acetate form);Kagliptin

    CAS No.:

    1415456-99-3

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Semaglutide

    Location:

    hangzhou

    Payment Terms:

    TT against copy of documents,D/P,L/C,TT against B/L draft before shipment

    Average lead Time:

    2

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2025

    Our company is a modern advanced enterprise specializing in production and exportation of APIs, Pharmaceutical intermediates, plant extracts etc. Our products are widely used in medicine, health care products, cosmetics, nutritional supplements and food additives areas. Our factory covers an area of 95 acres, the proposed construction of the plant will be GMP standards, the factory environment clean and tidy, rational layout, with large and medium-sized production workshop and repocessed shop. It is equipped with advanced equipment quality inspection and research center. Those products of both quality and technical content have reached the domestic advanced level. Since its establishment, the company has attached great importance to the team training and technical reform. Our modern production equipment guarantees for a fast and effective production with a superior degree of accuracy throughout the whole production line, everything is done in-house, processing, extraction, packaging and transportation of all links, ensuring maximum quality and efficiency. We are constantly research and development new ingredients and innovative new products, have earned the respect & Admiration from the worldwide customers. After years of continuous development, company has been accumulated rich experience in international trade and customer resources, established a stable customer base and perfect marketing service network. In addition, the company has established long-term technical cooperation with experts and professors from many universities and research institutes in the province.

  • Inquiry History
    62 Inquiries
    Country Product Purchase Quantity Date Posted
    Australia

    Cagrilintide

    20 MG Aug 17, 2026
    United Kingdom

    Cagrilintide

    10 MG Jul 31, 2026
    France

    Cagrilintide

    10 MG May 22, 2026
    Australia

    Cagrilintide

    4 MT Mar 9, 2026
    United States

    Cagrilintide

    15 MG Feb 25, 2026
    United States

    Cagrilintide

    10 PCS Dec 27, 2025
    United States

    Cagrilintide

    2 MT Dec 21, 2025
    United States

    Cagrilintide

    100 MG Oct 28, 2025
    United States

    cagrilintide

    2 MT Aug 8, 2025
    Philippines

    Retatrutide

    5 MG Aug 5, 2025
    China

    Cagrilintide

    100 G May 6, 2025
    United States

    cagrilintide

    5 MG Feb 18, 2025
    United States

    Cagrilintide

    3 MT Feb 7, 2025
    United States

    Cagrilintide

    100  Nov 12, 2024
    United States

    Cagrillintide Lyophilized powder

    100 MG Jul 4, 2024
    United States

    Cagrillintide Lyophilized powder

    1000 MG Apr 20, 2024
    United States

    Cagrilintide

    25 MG Aug 31, 2026
    United States

    Cagrlintide

    1 MT Jul 31, 2026
    United Kingdom

    cagrilintrude

    20 MG Jul 21, 2026
    United States

    Cagrilintide

    1 KG Jul 17, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.